Bluejay Diagnostics, Inc. BJDX 深 滬
已收盤 08-01 16:00:00 美东时间
1.50
0.000
0.00%
華盛通- 最 高1.52
- 今 開1.48
- 成交量 1.49万股
- 最 低 1.48
- 昨 收 1.50
- 總市值 224.13万
- 52周最高 18.25
- 市盈率 靜 --
- 換手率 1.00%
- 52周最低 1.46
- 委 比 98.51%
- 總股本 149.42万
- 歷史最高 50000.00
- 量 比 0.46
- 振 幅 2.67%
- 歷史最低 1.46
- 每 手 1
- 風險率 4.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bluejay Diagnostics Amends Agreement with Toray Industries
The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 23...
07-29 05:28
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of Rent the Runway, Inc. (NASDAQ:RENT) rose sharply in today's pre-marke...
06-06 18:52
【美股盤前】白宮安排川普與馬斯克通話！特斯拉飆漲近5%，美股全線反彈，投資者聚焦即將揭曉的非農數據
美股指全線反彈，穩定幣巨頭Circle盤前續漲；白宮安排川普與馬斯克通話，特斯拉反彈近5%；投資者聚焦即將公佈的即將非農數據。
06-06 11:38
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
Bluejay Diagnostics provided a mid-year update highlighting progress in its SYMON-II clinical trial aiming to validate IL-6 levels for predicting sepsis mortality. The company plans to submit a 510(k) application to the FDA by Q4 2027, targeting approval by Q3 2028. Manufacturing efforts include cartridge redevelopment, with potential outsourcing. Financially, the company has $5.7 million in cash, with plans to raise at least $30 million by 2027....
06-03 20:05
Bluejay Diagnostics Announces CTO Departure Effective May 30
An update from Bluejay Diagnostics ( ($BJDX) ) is now available. Bluejay Diagno...
05-29 05:50
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Longevity Health Holdings (NASDAQ:XAGE) shares moved upwards by 55.5% ...
05-22 05:06
Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.
05-14 13:59
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal
Bluejay Diagnostics (NASDAQ:BJDX) has entered into an agreement with institutional investors to purchase shares of common stock of the company for cash. The investors agreed to exercise the existing w...
04-08 05:29
Bluejay Diagnostics announces 1-for-8 reverse stock split
Bluejay Diagnostics (NASDAQ:BJDX) announced that the company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-8. The Reverse Stock Split will b...
2024-06-17 20:43
Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.68) by 161.76 percent. This is a 25.83 percent increase over losses of $(2.40) per share
2024-03-29 12:56
